Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells

Genome Research

Volumn 21, Issue 10, 2011, Pages 1601-1615

  Pirola, Luciano ^a   Balcerczyk, Aneta ^a   Tothill, Richard W ^a   Haviv, Izhak ^a   Kaspi, Antony ^a   Lunke, Sebastian ^a   Ziemann, Mark ^a   Karagiannis, Tom ^a   Tonna, Stephen ^a   Kowalczyk, Adam ^b   Beresford Smith, Bryan ^b   Macintyre, Geoff ^b   Kelong, Ma ^c   Hongyu, Zhang ^c   Zhu, Jingde ^c   El Osta, Assam ^a,d,e  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3;

ACETYLATION; ARTICLE; BLOOD VESSEL; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION PROFILING; GENE INDUCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROCESSING; SEQUENCE ANALYSIS; UPREGULATION; VASCULAR ENDOTHELIUM;

ACETYLATION; ACETYLTRANSFERASES; AORTA; CELLS, CULTURED; CHROMOSOMES, HUMAN; CPG ISLANDS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DNA METHYLATION; ENDOTHELIAL CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTONES; HUMANS; HYPERGLYCEMIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIMARY CELL CULTURE; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 80053559849     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.116095.110     Document Type: Article

References (57)

1. Araki Y, Wang Z, Zang C, Wood WH 3rd, Schones D, Cui K, Roh TY, Lhotsky B, Wersto RP, Peng W, et al. 2009. Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity 30: 912-925.
2. Bell CG, Teschendorff AE, Rakyan VK, Maxwell AP, Beck S, Savage DA. 2010. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics 3: 33. doi: 10.1186/1755-8794-3-33.
3. Benton RL, Maddie MA, Dincman TA, Hagg T, Whittemore SR. 2009. Transcriptional activation of endothelial cells by TGFb coincides with acute microvascular plasticity following focal spinal cord ischaemia/ reperfusion injury. ASN Neuro 1: e00015. doi: 10.1042/AN20090008.
4. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. 2009. An operational definition of epigenetics. Genes Dev 23: 781-783.
5. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. 2005. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 21: 4067-4068. (Pubitemid 41631851)
6. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME, El-Osta A. 2009. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58: 1229-1236.
7. Brinkman AB, Simmer F, Ma K, Kaan A, Zhu J, Stunnenberg HG. 2010. Whole-genome DNA methylation profiling using MethylCap-seq. Methods 52: 232-236.
8. Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820. (Pubitemid 34000785)
9. Chalmers J, Cooper ME. 2008. UKPDS and the legacy effect. N Engl J Med 359: 1618-1620.
10. Cooper ME, El-Osta A. 2010. Epigenetics: mechanisms and implications for diabetic complications. Circ Res 107: 1403-1413.
11. Dudoit S, Fridlyand J. 2002. A prediction-based resampling method for estimating the number of clusters in a dataset. Genome Biol 3: RESEARCH0036. doi: 10.1186/gb-2002-3-7-research0036.
12. Einstein F, Thompson RF, Bhagat TD, Fazzari MJ, Verma A, Barzilai N, Greally JM. 2010. Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS ONE 5: e8887. doi: 10.1371/journal.pone. 0008887.
13. El-Osta A, Wolffe AP. 2000. DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease. Gene Expr 9: 63-75.
14. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M. 2008. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205: 2409-2417.
15. The ENCODE Project Consortium 2007. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
16. Fazzari MJ, Greally JM. 2010. Introduction to epigenomics and epigenome wide analysis. Methods Mol Biol 620: 243-265.
17. Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, Andreesen R, Rehli M. 2006. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res 66: 6118-6128.
18. Guttman M, Amit I, Garber M, FrenchC, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al. 2009. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458: 223-227.
19. Harikrishnan KN, Bayles R, Ciccotosto GD, Maxwell S, Cappai R, Pelka GJ, Tam PP, Christodoulou J, El-Osta A. 2010. Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons. J Neurosci 30: 1494-1501.
20. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, Johnson BE, Fouse SD, Delaney A, Zhao Y, et al. 2010. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 28: 1097-1105.
21. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, et al. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459: 108-112.
22. Hofmann MA, Schiekofer S, Kanitz M, Klevesath MS, Joswig M, Lee V, Morcos M, Tritschler H, Ziegler R, Wahl P, et al. 1998. Insufficient glycemic control increases nuclear factor-κB binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care 21: 1310-1316. (Pubitemid 28365689)
23. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 2008. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359: 1577-1589.
24. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19: 187-191. (Pubitemid 28248804)
25. Katari S, Turan N, Bibikova M, Erinle O, Chalian R, Foster M, Gaughan JP, Coutifaris C, Sapienza C. 2009. DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum Mol Genet 18: 3769-3778.
26. Kowalczyk A, Bedo J, Conway T, Beresford-Smith B. 2011. The poisson margin test for normalization-free significance analysis of NGS data. J Comput Biol 18: 391-400.
27. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, et al. 2006. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929-1935. (Pubitemid 44497995)
28. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows- Wheeler transform. Bioinformatics 25: 1754-1760.
29. Ling C, Groop L. 2009. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 58: 2718-2725.
30. Macintyre G, Bailey J, Haviv I, Kowalczyk A. 2010. is-rSNP: a novel technique for in silico regulatory SNP detection. Bioinformatics 26: i524-i530.
31. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, et al. 2008. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766-770.
32. Miao F, Gonzalo IG, Lanting L, Natarajan R. 2004. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279: 18091-18097. (Pubitemid 38560579)
33. Miao F, Wu X, Zhang L, Yuan YC, Riggs AD, Natarajan R. 2007. Genome wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J Biol Chem 282: 13854-13863. (Pubitemid 47100501)
34. Miao F, Smith DD, Zhang L, Min A, Feng W, Natarajan R. 2008. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 57: 3189-3198.
35. Nair SS, CoolenMW, Stirzaker C, Song JZ, Statham AL, StrbenacD, Robinson MD, Clark SJ. 2011. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics 6: 34-44.
36. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-389. (Pubitemid 28269714)
37. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. 2005. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353: 2643-2653. (Pubitemid 41817713)
38. Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, Orchard TJ. 2009. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/ epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med 169: 1307-1316.
39. Park PJ. 2009. ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet 10: 669-680.
40. Pieper GM, Riaz ul H. 1997. Activation of nuclear factor-kB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol 30: 528-532.
41. Piga R, Naito Y, Kokura S, Handa O, Yoshikawa T. 2007. Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis 193: 328-334. (Pubitemid 47058120)
42. Roy S, Sala R, Cagliero E, Lorenzi M. 1990. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci 87: 404-408.
43. Schones DE, Zhao K. 2008. Genome wide approaches to studying chromatin modifications. Nat Rev Genet 9: 179-191. (Pubitemid 351271798)
44. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, et al. 2000. Genes expressed in human tumor endothelium. Science 289: 1197-1202. (Pubitemid 30650733)
45. Statham AL, Strbenac D, Coolen MW, Stirzaker C, Clark SJ, Robinson MD. 2010. Repitools: an R package for the analysis of enrichment-based epigenomic data. Bioinformatics 26: 1662-1663.
46. Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature 403: 41-45. (Pubitemid 30038513)
47. Suzuki M, Jing Q, Lia D, Pascual M, McLellan A, Greally JM. 2010. Optimized design and data analysis of tag-based cytosine methylation assays. Genome Biol 11: R36. doi: 10.1186/gb-2010-11-4-r36.
48. Thompson RF, Fazzari MJ, Niu H, Barzilai N, Simmons RA, Greally JM. 2010. Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J Biol Chem 285: 15111-15118.
49. Tomas E, Lin YS, Dagher Z, Saha A, Luo Z, Ido Y, Ruderman NB. 2002. Hyperglycemia and insulin resistance: possible mechanisms. Ann N Y Acad Sci 967: 43-51. (Pubitemid 34721892)
50. UK Prospective Diabetes Study (UKPDS) Group. 1998. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853.
51. Vaquero A, Reinberg D. 2009. Calorie restriction and the exercise of chromatin. Genes Dev 23: 1849-1869.
52. Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R. 2008. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci 105: 9047-9052.
53. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh TY, Peng W, Zhang MQ, et al. 2008. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40: 897-903. (Pubitemid 351913645)
54. Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, Zhao K. 2009. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138: 1019-1031.
55. Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. 2002. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287: 2563-2569.
56. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R. 1999. Hyperglycemia-induced activation of nuclear transcription factor κB in vascular smooth muscle cells. Diabetes 48: 855-864. (Pubitemid 29153087)
57. Zhao B, Bowden RA, Stavchansky SA, Bowman PD. 2001. Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays. Am J Physiol Cell Physiol 281: C1587-C1595.